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Abstract
Human African Trypanosomiasis (HAT) is a potentially fatal parasitic infection caused by the
trypanosome sub-species Trypanosoma brucei gambiense and T. b. rhodesiense transmit-
ted by tsetse flies. Currently, global HAT case numbers are reaching less than 1 case per
10,000 people in many disease foci. As such, there is a need for simple screening tools and
strategies to replace active screening of the human population which can be maintained
post-elimination for Gambian HAT and long-term for Rhodesian HAT. Here, we describe the
proof of principle application of a novel high-resolution melt assay for the xenomonitoring of
Trypanosoma brucei gambiense and T. b. rhodesiense in tsetse. Both novel and previously
described primers which target species-specific single copy genes were used as part of a
multiplex qPCR. An additional primer set was included in the multiplex to determine if sam-
ples had sufficient genomic material for detecting genes present in low copy number. The
assay was evaluated on 96 wild-caught tsetse previously identified to be positive for T. bru-
cei s. l. of which two were known to be positive for T. b. rhodesiense. The assay was found
to be highly specific with no cross-reactivity with non-target trypanosome species and the
assay limit of detection was 104 tryps/mL. The qPCR successfully identified three T. b. rho-
desiense positive flies, in agreement with the reference species-specific PCRs. This assay
provides an alternative to running multiple PCRs when screening for pathogenic sub-spe-
cies of T. brucei s. l. and produces results in less than 2 hours, avoiding gel electrophoresis
and subjective analysis. This method could provide a component of a simple and efficient
method of screening large numbers of tsetse flies in known HAT foci or in areas at risk of
recrudescence or threatened by the changing distribution of both forms of HAT.
Author summary
With global cases of Human African Trypanosomiasis (HAT) reaching pre-elimination
numbers, identifying areas of trypanosome transmission becomes increasingly important.
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With decreasing numbers of cases, the cost of identifying each positive case increases.
Screening for trypanosomes in tsetse flies instead of in the human host allows for a faster,
more cost-effective and efficient method of detecting areas in which parasite transmission
is on-going. Molecular tools such as PCR play a critical role in molecular identification of
parasites in vectors. However, at present, multiple PCRs are required to confirm the pres-
ence or absence of human infective trypanosomes. Here we present a novel assay which
allows for the screening of both species of trypanosomes responsible for HAT in one
assay. This method eliminates the need for multiple assays per sample, produces results
which are easier to interpret, and reduces the risk of contamination of samples. We found
the assay to be as sensitive as the current gold-standard PCR when evaluated on a subset
of wild tsetse flies. With further field evaluation, this method could provide an alternative
monitoring method for HAT, which can be used leading up to elimination and main-
tained once elimination has been achieved.
Introduction
Human African Trypanosomiasis (HAT) is a potentially fatal disease caused by subspecies of
Trypanosoma brucei s. l. transmitted by the bite of an infected tsetse fly (Glossina spp). HAT
consists of two forms of the disease, each with its own distinct parasite, vectors, disease pathol-
ogy, treatment and geographical distribution. Gambian HAT (gHAT), caused by Trypanosoma
brucei gambiense, is a largely anthroponotic disease found across central and west Africa and
accounts for the large majority of HAT cases (>97%) [1]. Gambian HAT can remain asymp-
tomatic for months to years with symptoms often presenting once the infection has signifi-
cantly advanced. Conversely, Rhodesian HAT (rHAT), caused by Trypanosoma brucei
rhodesiense, is a zoonosis with occasional human infection, and represents less than 3% of all
HAT cases. The World Health Organisation (WHO) has targeted the elimination of HAT as a
public health problem by 2020, defined as less than 1 new case per 10, 000 inhabitants in at
least 90% of endemic foci and fewer than 2000 cases reported globally [2]. Due to the zoonotic
nature of rHAT, this WHO target is applicable to gHAT only. With gHAT on the brink of
elimination and rHAT persisting in several foci across East and Southern Africa [3], it is cru-
cial to identify any remaining active cases, foci of transmission and areas of resurgence. The
epidemiology of the two forms of HAT differ greatly and therefore monitoring and screening
strategies also differ. Monitoring gHAT is largely reliant on the screening of the at-risk human
population and treatment of cases [4]. Accurate estimates of disease prevalence require high
rates of coverage, which can be difficult to achieve, particularly in areas affected by conflict
and political instability [5] and where prevalence approaches <1 case per 10,000. As a result,
there has been emphasis on the development of rapid diagnostic tests (RDTs) and field-
friendly screening tools [6–10]. In comparison to gHAT, there has been little progress or
investment into the development of a screening tool for rHAT with current emphasis on pas-
sive case detection and control of the vector population. A reliance on passive detection results
in a delay in the identification and treatment of infected individuals, both of which are crucial
for the control of disease transmission.
With declining numbers of cases, active screening programmes are no longer cost-effective
[11] and there is a need for a monitoring tool which can be maintained sustainably for rHAT
and post-elimination for gHAT. Xenomonitoring, the screening of vectors for the presence of
parasites, provides a potential alternative to host sampling. This method has already been suc-
cessfully utilised as a surveillance tool within the Lymphatic Filariasis elimination programme
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[12–14]. Vectors are often routinely collected as part of vector control programmes and as
such, making use of this material may prove to be more economical than active screening of
either human or animal populations. Additionally, screening vectors for infection is often less
time-consuming and with efficient processing, can provide a view of disease transmission in
real-time. Microscopy has been traditionally used for vector screening due to its low cost, high
specificity and ease of use in-field. However, the sensitivity of microscopy is variable, it is
labour intensive and morphological identification of T. brucei gambiense and T. b. rhodesiense
trypanosomes is not possible [15,16].
The development of molecular tools has provided alternatives to traditional screening
methods. PCR is widely used for the detection of trypanosome DNA, with highly sensitive
assays developed for T. brucei s. l. [17] which includes T. b. gambiense and T. b. rhodesiense
along with the animal trypanosome T. b. brucei. Successful amplification indicates the presence
of one of the members of T. brucei s. l. but does not identify which member of T. brucei s. l. is
present. Identification of T. b. gambiense and T. b. rhodesiense is reliant on the detection of
specific single-copy genes (TgsGP [18] and SRA [19,20] respectively) for each subspecies. For
detection of these low copy genes, the presence of sufficient genetic material is crucial. A nega-
tive result may indicate the absence of the target species or simply that insufficient DNA is
present. To differentiate between these two scenarios, primers have been designed to screen
for other single-copy genes [21], namely the single-copy phospholipase-C (PLC) gene, present
in all members of T. brucei s. l. [22–25]. Samples found to have sufficient DNA can then be
screened using primers specific for T. brucei s. l. subspecies.
High-resolution melt analysis (HRM) is a post-qPCR analysis method which can be used to
detect heterogeneity within nucleotide sequences and has previously been used for the detec-
tion of other parasite species [26–28]. A fluorescent dye is added to the PCR reaction which
intercalates into double stranded DNA. Following amplification, the amplicon is heated gradu-
ally causing the strands to separate. Separation of the double strands releases the incorporated
dye causing a drop in fluorescence. The rate of DNA strand disassociation and the temperature
at which it separates (Tm) is dependent on the amplicon’s nucleotide sequence. Different
sequences will have different melting temperatures which can then be used as a diagnostic
identifier. HRM is a closed tube process resulting in a reduced risk of contamination and pro-
duces results in approximately two hours circumventing gel electrophoresis, making it a faster,
more specific alternative to traditional PCR. Multiplexing allows for the screening of a number
of targets simultaneously, making sample processing more efficient.
Objectives
We aim to develop a qPCR HRM assay designed to distinguish between the two human infec-
tive sub-species of T. brucei s. l. To improve the reliability of the assay primers were included
to determine if sufficient DNA is present for the sub-species primers to work. To meet this
objective we first designed and identified suitable primers that are compatible with the HRM
qPCR, followed by assay optimisation and evaluation of sensitivity and specificity. Finally, the




Ethical approval for this work was obtained from the Commission for Science and Technology
(Costech) in Tanzania (permit number 2016-33-NA-2014-233). The samples from Tanzania
were collected under the auspices of a BBSRC funded project (“Life on the edge: tackling
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human African trypanosomiasis on the edge of wilderness areas”, BB/L019035/1; COSTECH
research permit number 2014-280-NA-2014-223).
Primers
In order to be compatible with a HRM qPCR assay, primers that produced an amplicon of
150–350 base pairs with distinct melt temperatures were sought. Based on the literature, novel
T. b. rhodesiense primers were derived from the sequence of a sub-species-specific serum-resis-
tance-associated (SRA) protein gene (accession number AF097331.1). The primers for T. b.
gambiense, previously designed and published by Radwanska et al. [29] were found to be com-
patible with the HRM qPCR method. These primers target the sub-species-specific glycopro-
tein (TgsGP: accession number AJ277951). The third primer set was designed to identify the
presence of sufficient genetic material. These primers amplify a single-copy phospholipase-C
(PLC) gene found in all members of the Trypanozoon group [22–25].
Assay optimisation
To optimise the new HRM assay, the specificity of the multiplexed assay was evaluated using
DNA from a range of non-target trypanosome species: Trypanosoma congolense Savannah
(Gam2), T. congolense Forest (ANR3), T. congolense Kilifi (WG84), T. simiae (TV008), T. god-
freyi (Ken7), T. vivax (Y486) and T. grayi (ANR4). Additionally, cross-reactivity of T. b. gam-
biense and T. b. rhodesiense primers against non-target T. brucei s. l. sub-species (i. e. T. b.
rhodesiense, T. b. brucei and T. b. gambiense) DNA was tested. Each species’ DNA was run in
triplicate along with negative water controls and target species positive controls.
The analytical sensitivity of the assay was assessed using a tenfold dilution series of T. b.
gambiense and T. b. rhodesiense DNA obtained from culture which ranged from an estimated
106 to 101 tryps/mL, with each concentration run in duplicate. Quantification of DNA in
terms of trypanosomes was calculated using concentrations of DNA as read by a Qubit 2.0
fluorometer (Invitrogen) and an assumed approximate DNA quantity of 0.1pg per trypano-
some [30]. TgsGP and SRA PCR were run alongside on the same dilution series for a direct
comparison of sensitivities [21,29].
Screening of field samples
A subsample of wild-caught tsetse were selected to validate the HRM performance on field
samples. The flies had been captured in 2015–2016 in Tanzania as part of the study reported
by Lord et al [31]. Full methods are described in Lord et al [31], but in brief, a total of 5,986
tsetse were trapped using odour-baited Nzi traps deployed at sites in Grumeti and Ikorongo
wildlife reserve, and Serengeti National Park. Captured flies were stored individually in 100%
ethanol at room temperature and brought to LSTM for analysis. DNA extraction was carried
out using Genejet DNA purification kit (Thermo K0721) according to the manufacturer’s
instructions. Flies were screened for T. brucei s. l. and T. congolense Savannah using TBR [17]
and TCS PCR [32] respectively. Both primer sets target satellite repeat sequences specific to
each species. Flies positive for T. brucei s. l. were then screened for T. b. rhodesiense using SRA
PCR.
PCR
A subsample of 96 flies positive by TBR PCR were used in this study, of which two had been
previously found to be positive for T. b. rhodesiense [31]. The species composition of the tsetse
was 69.8% Glossina pallidipes (67/96) and 30.2% G. swynnertoni (29/96). Of the 96 T. brucei s.
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l. positive flies, 11.5% (11/96) were also found to be positive for T. congolense Savannah. Flies
were re-screened using TBR [17] and SRA PCR [21] to reconfirm the presence and integrity of
parasite DNA. TBR PCR conditions were as follows: initial denaturation at 95˚C for 10 min-
utes, 40 cycles of 95˚C for 30 seconds, 63˚C for 90 seconds and 72˚C for 70 seconds followed
by an extension step at 72˚C for 10 minutes. SRA PCR conditions were: initial denaturation at
95˚C for 10 minutes, 40 cycles of 94˚C for 30 seconds, 63˚C for 90 seconds and 72˚C for 70
seconds followed by an extension step at 72˚C for 10 minutes. Additionally, flies were screened
for T. b. gambiense using TgsGP PCR [29] using the following conditions: denaturation at
95˚C for 10 minutes, 40 cycles of 95˚C for 30 seconds, 63˚C for 90 seconds and 72˚C for 70
seconds followed a 10 minute extension at 72˚C.
HRM qPCR
All 96 flies were screened using the novel multiplexed HRM qPCR. HRM reactions were
run in a total volume of 12.5μl consisting of 2.5μl DNA template, 6.25 μl HRM Master Mix
(Thermo-start ABgene, Rochester, New York, USA), 3.25 μl sterile DNase/RNase free water
(Sigma, ST. Louis, USA) and 400nM of all forward and reverse primers were included in a
multiplex. Reactions were carried out on a Rotor-Gene 6000 real-time PCR machine (Qiagen
RGQ system). The following protocol was followed: denaturation at 95˚C for 5 minutes fol-
lowed by 40 cycles and denaturation for 10 seconds at 95˚C per cycle, annealing and exten-
sion for 30 seconds at 58˚C, and final extension for 30 seconds at 72˚C. The melting step ran
from 75˚C to 90˚C with a temperature increase of 0.1˚C every 2 seconds. A threshold was set
at 10% of the maximum normalized fluorescence (dF/dT) of the highest peak, with all peaks




One primer-pair per target was selected based on successful amplification, distinct Tm and
production of a clear peak. Product sizes for each amplicon ranged from 134–319 base pairs
(Table 1) with peak temperatures ranging from 79.2˚C to 87.5˚C. To allow for automated call-
ing of peaks, bin widths of 1.5˚C (0.75˚C either side of diagnostic Tm) were set for each target
(Fig 1).
Table 1. HRM and PCR primers used for identification of single-copy gene targets of T. b. rhodesiense, T. b. gambiense and T. brucei s. l. HRM primers were run in
multiplex whilst PCR primers were run in singleplex. �This primer set was run in multiplex in HRM and in singleplex in PCR.
Primer Species Primer sequence 5’-3’ Product size (bp) Product Tm (˚C) Reference Assay
PLC1 Trypanozoon CAGTGTTGCGCTTAAATCCA 319 79.1 This study HRM
PLC2 CCCGCCAATACTGACATCTT
TbRh1 T. b. rhodesiense GAAGCGGAAGCAAGAATGAC 134 84.2 This study HRM
TbRh2 GGCGCAAGACTTGTAAGAGC
TgsGP1 T. b. gambiense GCTGCTGTGTTCGGAGAGC 308 87.5 [29] HRM and PCR�
TGsGP2 GCCATCGTGCTTGCCGCTC
657 Trypanozoon CGCTTTGTTGAGGAGCTGCAA GCA 324 - (21) PCR
658 TGCCACCGCAAAGTCGTTATT TCG
SRA 02 T. b. rhodesiense AGCCAAAACCAGTGGGCA 669 - (21) PCR
SRA 03 TAGCGCTGTCCTGTAGACGCT
https://doi.org/10.1371/journal.pntd.0008308.t001
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Analytical specificity and sensitivity
No non-specific amplification was seen when the assay was challenged with a range of non-tar-
get trypanosome species, namely T. congolense (Savannah, Kilifi and Forest subgroups), T.
vivax, T. simiae, T. simiae Tsavo, T. godfreyi and T. grayi. The limit of detection was found to
be an estimated 104 trypanosomes/mL for T. b. gambiense and T. b. rhodesiense using purified
DNA from culture (S4 Fig). When the performance of the HRM was compared to TgsGP and
SRA PCR on the same DNA dilution series, the HRM was as sensitive at detecting T. b. gam-
biense DNA and tenfold more sensitive for T. b. rhodesiense DNA (S2 and S3 Figs).
Screening of field samples
All flies (96/96) were positive by TBR PCR when initially rescreened. Using the multiplexed
HRM, PLC positive control peaks were produced by 43 samples (44.8%), indicating sufficient
target DNA for identification of either T. b. gambiense or T. b. rhodesiense. PLC PCR identified
19 samples (19.8%) with sufficient DNA quantity (Table 2). All samples which were positive by
PLC PCR were also positive by HRM. None of the flies positive for T. congolense Savannah
produced any non-specific amplification. Three flies (3.1%) were identified as positive for T. b.
rhodesiense DNA both by HRM and PCR (Table 2), all of which also produced PLC peaks and
were positive by PLC PCR (Fig 2). No flies were found to be positive for T. b. gambiense
through either PCR or HRM. Flies that were positive for PLC but negative for T. b. gambiense
or T. b. rhodesiense were considered to be infected with livestock trypanosome T. b. brucei.
Discussion
Here we describe a novel high-resolution melt analysis for the detection and differentiation of
T. b. rhodesiense and T. b. gambiense. This multiplexed assay screens for both pathogenic try-
panosome species simultaneously with the addition of a third primer set to identify the
Fig 1. High resolution melt profile of phospholipase-C (PLC), T. b. rhodesiense (TBR) and T. b. gambiense (TBG) targets. Normalized fluorescence
dF/dt is plotted against degrees ˚C (deg.) The melt temperatures for each peak were 79.1˚C for PLC, 84.2˚C for T. b. rhodesiense and 87.5˚C for T. b.
gambiense. The positivity threshold is shown in red and target specific bins indicated in grey.
https://doi.org/10.1371/journal.pntd.0008308.g001
Table 2. Breakdown of results of HRM and PCR on 96 field caught tsetse.
HRM PCR
Tsetse species Total screened (N) PLC positive (%) SRA positive (%) TgsGP positive (N) PLC positive (N) SRA positive (N) TgsGP positive (N)
G. pallidipes 67 34 (50.7) 2 (3.0) 0 15 (22.4) 2 (3.0) 0
G. swynnertoni 29 9 (31.0) 1 (3.4) 0 4 (13.8) 1 (3.4) 0
https://doi.org/10.1371/journal.pntd.0008308.t002
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presence of sufficient DNA to detect single-copy genes, acting as a positive control. The assay
demonstrated high specificity with no cross-reaction with other non-target trypanosome
species also transmitted by tsetse. The limit of detection of the HRM was lower than those
reported in the literature for TgsGP [29] and SRA PCR [21]. However, when the three assays
were compared directly against a dilution series of DNA, HRM was found to be as sensitive as
TgsGP PCR and tenfold more sensitive than SRA PCR. The assay identified three wild caught
tsetse flies to be positive for T. b. rhodesiense DNA. The three T. b. rhodesiense positives
included two flies that had been previously identified by Lord et al [31]. All three flies includ-
ing the additional fly that was identified by the HRM were positive by SRA PCR. However, the
Ct value of the additional SRA positive was 30.5 in comparison to the two previously recorded
positives which had Ct values of 21.1 and 21.8. This may indicate a lower DNA quantity and
may represent a sample at the threshold of PCR detection. Of the 96 flies screened, 44.8% were
positive for the universal-Trypanozoon PLC gene by HRM, indicating that they contained suf-
ficient DNA for single-copy gene detection and therefore the detection of the SRA or TgsGP
targets; if present. The remaining 55.2% of tsetse that were negative for the single-copy PLC
gene can be assumed to have insufficient DNA present for the detection of the sub-species tar-
gets, we can therefore not rule these out as being negative for either T. b. gambiense or T. b.
rhodesiense. Similar results have been reported in previous studies [33] and such a result is
unsurprising when comparing the copy numbers, with TBR primers targeting a ~10,000 copy
region and the sub-species primers targeting a single-copy gene, and presents an ongoing chal-
lenge. The two methods also differed in the number of flies positive for the single-copy PLC
gene with the HRM method identifying a higher number of flies, indicating a greater sensitiv-
ity. This is likely due to the difficulty in identifying faint bands on a gel compared to the ability
to better quantify a positive result using qPCR. When the Ct values of flies positive by HRM
and PCR were compared to those that were only positive by HRM, the Cts of those positive by
HRM only were slightly higher suggesting a potential failure of the PCR due to lower quantities
of DNA in these samples (S5 Fig).
The method has three advantages over traditional PCR methods. First, the HRM time to
result of�2 hours is faster than PCR followed by gel electrophoresis which can take over three
hours for product amplification and visualisation. Second, this is a closed-tube assay which
reduces contamination risk. Finally, it does not require interpretation of gel electrophoresis
results. Through the use of detection bins, sample processing can also be automated, further
Fig 2. Melt profile of field samples. Three samples were identified as T. b. rhodesiense due to the production of both PLC and TBR peaks
(samples:1027, 1079 and 1137). Samples which only produced PLC peaks were considered to be T. b. brucei (samples: 2362,2377 and 2380). The
TBR positive control was T. b. rhodesiense DNA and the negative control used was nuclease free water. Normalized fluorescence dF/dt is plotted
against degrees ˚C (deg.) with threshold indicated in red and species-specific bins shown in grey.
https://doi.org/10.1371/journal.pntd.0008308.g002
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speeding up and simplifying data analysis. The simple and fast nature of this method indicates
it could be suitable for the high-throughput processing of tsetse. With prevalence of T. b. gam-
biense in tsetse from HAT foci predicted to be as low as 1 in 105 [34], there is a need for a xeno-
monitoring tool which can be applied to large numbers of samples. At present, this method is
not suitable to a low-resources setting because it requires a qPCR machine, however with fur-
ther optimisation this technique could be applicable to more field-friendly technologies such
as the Magnetic Induction Cycler (Mic) (Bio molecular Systems). This method has the poten-
tial to provide the basis of a real-time trypanosome transmission monitoring platform,
enabling timely reactive measures by disease control programmes. Furthermore, with the risk
of traditionally distinct geographical distributions of both Rhodesian and Gambian HAT
changing due to the movement of livestock [35], human migration [36] and climate change
[37–40], it may become increasingly important to screen simultaneously for both trypanosome
species. The HRM allows for this and removes the risk of presumptive screening based on his-
toric disease distributions.
Study limitations
The authors acknowledge that the reliance of low copy genes for target identification is a limit-
ing factor of the described diagnostic assay. However, at present these single copy genes are
the only identifiers of members of the T. brucei s. l. and so pose a challenge to any diagnostic
method based on these targets. This study was also challenged by a small number (96) of field
caught flies from a rHAT focus and none from a gHAT focus where tsetse infected with T. b.
gambiense might be present. Consequently, assay performance on field samples could only be
evaluated for T. b. rhodesiense. Due to trypanosome prevalence in HAT foci predicted to be
very low [34], obtaining sufficient field samples for any assay validation will be difficult. As
control efforts such as active screening and treating the human population, combined with
tsetse control, the numbers of infected tsetse will likely decline even further [41–44]. The
authors are currently in planning to validate this method in a gHAT focus. Additionally, the
field samples had only been screened for the presence of T. brucei s. l. and T. congolense Savan-
nah. Studies of flies caught in this area suggest that these flies would have likely been infected
with other trypanosome species [45,46] however this cannot be confirmed. Further validation
using field caught flies with known infections with other non-target species would provide
further evidence of the specificity of this method. Another limitation of this study was the
comparison of only two methods for the identification of T. b. rhodesiense when there are alter-
native molecular methods available for HAT detection such as Trypanozoon sub-species spe-
cific LAMP [47,48] assays, which have demonstrated a high degree of sensitivity. Comparison
between a wider range of methods would help assess HRM’s potential as a screening tool for
human trypanosomes. A final limitation of this assay, as with all assays targeting DNA, is
the inability to differentiate between a tsetse with an active infection or one with a transient
one. Similarly, the assay is unable to determine whether a fly has a mature infection and is
therefore capable of transmitting the disease. By using RNA as a target it may be possible to
identify an active infection and determine what stage of infection it is; either mature or imma-
ture. Detailed analyses of RNA transcripts would be required to overcome this challenge.
In order to overcome these limitations follow-up studies will be conducted in order to
more fully validate the HRM assay against larger field samples for both T. b. gambiense and T.
b. rhodesiense.
In summary, we describe the development of a novel HRM assay for the detection and dis-
crimination of human African trypanosomes in tsetse flies. The assay also incorporates an
internal control, identifying samples with sufficient genomic material. The closed tube nature
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of the assay in addition to the relatively fast time and potential for automated calling lends
itself to use in high throughput xenomonitoring surveillance campaigns for HAT.
Supporting information
S1 Fig. Molecular analysis workflow of field caught flies.
(TIF)
S2 Fig. Gel image showing the results of TgsGP PCR on a serial dilution of T. b. gambiense
DNA from 106 tryps/mL to 101 tryps/mL. Marker (M) is 100bp (Invitrogen).
(TIF)
S3 Fig. Gel image showing the results of SRA PCR on a dilution series of T. b. rhodesiense
DNA on concentrations from 106 tryps/ml to 101 tryps/mL. Marker (M) is 100bp (Invitro-
gen).
(TIF)
S4 Fig. Limit of detection of multiplexed HRM qPCR. DNA concentrations for T. b. gam-
biense and T. b. rhodesiense range from 106 to 101 tryps/mL. Positivity threshold is shown in
red and target specific bins indicated in grey.
(TIF)
S5 Fig. Ct values of flies positive by HRM only and both HRM qPCR and PCR.
(TIF)
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PLoS Negl Trop Dis [Internet]. 2015 Feb 2 [cited 2018 Jun 20]; 9(2):e0003480. Available from: http://dx.
plos.org/10.1371/journal.pntd.0003480 PMID: 25642701
8. Bisser S, Lumbala C, Nguertoum E, Kande V, Flevaud L, Vatunga G, et al. Sensitivity and Specificity of
a Prototype Rapid Diagnostic Test for the Detection of Trypanosoma brucei gambiense Infection: A
Multi-centric Prospective Study. PLoS Negl Trop Dis. 2016; 10(4). https://doi.org/10.1371/journal.pntd.
0004608 PMID: 27058033
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